scispace - formally typeset
Search or ask a question
Institution

Roussel Uclaf

About: Roussel Uclaf is a based out in . It is known for research contribution in the topics: Alkyl & Alkoxy group. The organization has 1888 authors who have published 2338 publications receiving 36508 citations.
Topics: Alkyl, Alkoxy group, Aryl, Carbon, Carboxylic acid


Papers
More filters
Journal ArticleDOI
TL;DR: Results indicate that trandolapril is a more potent (by a factor of about 30) inhibitor of ACE than enalapril and causes a greater degree of regression of cardiac hypertrophy.
Abstract: The dose-related effects of trandolapril on serum angiotensin-converting enzyme (ACE) activity, blood pressure and cardiac hypertrophy were studied after 2-week oral treatment in adult spontaneously hypertensive rats. Trandolapril caused a dose-dependent decrease in mean blood pressure at doses of 0.03-3 mg/kg. Inhibition of serum ACE was demonstrated by even the lowest dose (-9% at 0.003 mg/kg), was about 40% at 0.03 mg/kg, and rose to 84% at 3 mg/kg. Regression of cardiac hypertrophy (heart:body weight) was seen at doses of trandolapril as low as 0.03 mg/kg (-5.1%), which was also the minimal effective antihypertensive dose. Clear dose-response curves were observed for trandolapril from 0.03 mg/kg upwards with respect to hypotensive effect and regression of cardiac hypertrophy, which were not seen with enalapril. Enalapril had no significant effect on plasma ACE activity except at the highest dose (10 mg/kg), despite demonstrating hypotensive effects with smaller doses. These results indicate that trandolapril is a more potent (by a factor of about 30) inhibitor of ACE than enalapril (only 34% inhibition at 10 mg/kg) and causes a greater degree of regression of cardiac hypertrophy.

8 citations

Patent
13 Apr 1992
TL;DR: A method of treating ovarian cancer in warm-blooded animals comprising intraperitoneally administering to warmblooded animals by perfusion a recombinant polypeptide of human gamma interferon type with a specific activity at least equal to 1×10 7 U/mg in an anti-cancer effective amount is described in this article.
Abstract: A method of treating ovarian cancer in warm-blooded animals comprising intraperitoneally administering to warm-blooded animals by perfusion a recombinant polypeptide of human gamma interferon type with a specific activity at least equal to 1×10 7 U/mg in an anti-cancer effective amount

8 citations

Journal ArticleDOI
E. Toromanoff1
TL;DR: In this article, the steric course of the 1,4-opening of cisoid and transoid diene monooxide incorporated in mono or polycyclic structures is analyzed and the stereochemistry of the reverse reaction corresponding to diene polyoxide formation from a γ-bromo-α,β-unsaturated-cyclohexanol can also be predicted.

8 citations

Journal ArticleDOI
TL;DR: Daily administration of increasing doses of R2323, a compound with antiprogestin activity, caused a progressive inhibition of tumor development, and there was no significant change of receptor levels for estradiol, progesterone or prolactin in tumor tissue nor of plasma Prolactin concentrations, whereas plasma LH levels were markedly decreased after R23 23 treatment.

8 citations


Authors

Showing all 1888 results

NameH-indexPapersCitations
Fernand Labrie11088548308
Lionel H. Opie8451925964
Alain Bélanger7024416469
Michel J. Tremblay5327310485
Pierre Monsan512168049
Samir Z. Zard5057510739
Alejandro Aruffo4712314084
Samuel S.C. Yen47966865
Dominique Maraninchi471888108
Serge Erlinger461528200
Romain Lefebvre402215269
William B. Motherwell393056357
Jean-Pierre Raynaud381045075
André Lemay381144264
Patrick J. Creaven321023435
Network Information
Related Institutions (5)
Merck & Co.
48K papers, 1.9M citations

85% related

Novartis
50.5K papers, 1.9M citations

85% related

Pfizer
37.4K papers, 1.6M citations

84% related

Eli Lilly and Company
22.8K papers, 946.7K citations

84% related

AstraZeneca
23.4K papers, 938.2K citations

82% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20181
20114
20104
20091
20084
20072